MedTrace Logo

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

NCT04267796 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-16

Study results available
· View outcomes & findings →

Summary

This trial studies how well a lifestyle intervention works in reducing breast cancer risk through changing body composition and decreasing inflammation in normal weight women. This trial may help researchers learn more about diet and exercise programs designed to decrease body fat in postmenopausal women who are of normal weight but have an elevated risk of breast cancer because of excess body fat.

Conditions

  • Breast Carcinoma

Interventions

OTHER

Aerobic Exercise

Complete aerobic training

OTHER

Dietary Intervention

Receive diet recommendations from health coach or registered dietitian

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Resistance Training

Complete high-resistance circuit training sessions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Foundation for Women's Cancers

    collaborator UNKNOWN

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Karen M Basen-Engquist · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-25
Primary Completion
2025-06-13
Completion
2026-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267796 on ClinicalTrials.gov